Garner Thomas
SEC insider (Form 3/4/5 filer). CIK 0001996325. EVP, Chief Commercial Officer at ACADIA PHARMACEUTICALS INC (ACAD). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 6, 2026. Located in SAN DIEGO, CA.
Companies Garner Thomas has filed insider reports for
- ACADIA PHARMACEUTICALS INC (ACAD): Officer, EVP, Chief Commercial Officer
Garner Thomas
CIK: 0001996325
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACADIA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
97.9K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
28.5K shares- - Dec 9, 2024ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
235.8K shares- - Dec 9, 2024ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
45.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 97,947 | - | - | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 28,493 | - | - | Direct |
| Dec 9, 2024 | ACAD ACADIA PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 235,849 | - | - | Direct |
| Dec 9, 2024 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 45,372 | - | - | Direct |
1-4 of 4 transactions